UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial

Annals of internal medicine, 2016-11, Vol.165 (9), p.625

2016

Volltextzugriff (PDF)

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

Hepatology (Baltimore, Md.), 1998-05, Vol.27 (5), p.1403-1407

1998

Volltextzugriff (PDF)

Treatment with siRNA JNJ-73763989 plus nucleos (t)ide analogue (NA) decreases HBsAg and HDV RNA levels in patients with chronic hepatitis D (CHD): part 1 of the REEF-D study

JOURNAL OF HEPATOLOGY, 2023, Vol.78, p.S34

2023

Volltextzugriff (PDF)

A longitudinal analysis of hepatitis C virus replication following liver transplantation

Gastroenterology (New York, N.Y. 1943), 1996-01, Vol.110 (1), p.167-177

1996

Volltextzugriff (PDF)

Combination Low-Dose Hepatitis B Immune Globulin and Lamivudine Therapy Provides Effective Prophylaxis Against Posttransplantation Hepatitis B

Liver transplantation, 2000-07, Vol.6 (4), p.429-433

2000

Volltextzugriff (PDF)

Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy

Clinical nutrition (Edinburgh, Scotland), 2005-04, Vol.24 (2), p.288-296

2005

Volltextzugriff (PDF)

Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery

Annals of surgery, 2001-08, Vol.234 (2), p.245-255

2001

Volltextzugriff (PDF)

Efficacy and safety of Sofosbuvir/Velpatasvir for the treatment of treatment-naive, non-cirrhotic patients with chronic hepatitis C genotype 3 infection: integrated analysis of three phase 3 clinical trials

JOURNAL OF VIRAL HEPATITIS, 2018, Vol.25, p.196

2018

Volltextzugriff (PDF)

Liver transplantation for HCV-associated liver cirrhosis: Predictors of outcomes in a population with significant genotype 3 and 4 distribution

Liver transplantation, 2003-04, Vol.9 (4), p.339-347

2003

Volltextzugriff (PDF)

Efficacy and Safety of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Treatment-Naive Patients with Chronic HCV Genotype 3: An Integrated Phase 2/3 Analysis

HEPATOLOGY, 2017, Vol.66, p.35A

2017

Volltextzugriff (PDF)

Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From Phase 2 and Phase 3 Trials

HEPATOLOGY, 2014, Vol.60, p.1145A

2014

Volltextzugriff (PDF)

Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods

Transplantation, 1997-06, Vol.63 (12), p.1803

1997

Volltextzugriff (PDF)

Ribavirin therapy for hepatitis C infection following liver transplantation

Transplant international, 1995-01, Vol.8 (1), p.61-64

1995

Volltextzugriff (PDF)

Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation

Transplantation, 1999-01, Vol.67 (1), p.78

1999

Volltextzugriff (PDF)

Colonoscopy in unexplained lower gastrointestinal bleeding

New Zealand medical journal, 1992-02, Vol.105 (927), p.31

1992

Volltextzugriff (PDF)

Low-cost, simultaneous, single-sequence genotyping of the HLA-A, HLA-B and HLA-C loci

Tissue antigens, 2006-07, Vol.68 (1), p.28-37

2006

Volltextzugriff (PDF)

Upper gastrointestinal endoscopy in patients with human immunodeficiency virus infection: is it worthwhile?

New Zealand medical journal, 1992-11, Vol.105 (946), p.475

1992

Volltextzugriff (PDF)

Neurological disease in patients with human immunodeficiency virus infection

New Zealand medical journal, 1992-02, Vol.105 (928), p.49

1992

Volltextzugriff (PDF)

Fulminant hepatic failure in a young mother

Australian and New Zealand Journal of Medicine, 1992-04, Vol.22 (2), p.142-143

1992

Volltextzugriff (PDF)

The Impact of Musculoskeletal Injuries Sustained in Road Traffic Crashes on Work-Related Outcomes: A Systematic Review

International journal of environmental research and public health, 2021-11, Vol.18 (21), p.11504

2021

Volltextzugriff (PDF)

Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

The New England journal of medicine, 1996-03, Vol.334 (13), p.815-821

1996

Volltextzugriff (PDF)

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

The New England journal of medicine, 2000-12, Vol.343 (23), p.1666-1672

2000

Volltextzugriff (PDF)

Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47

Blood, 2003-01, Vol.101 (1), p.338-344

2003

Volltextzugriff (PDF)

Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C

PharmacoEconomics, 2003, Vol.21 (5), p.341-349

2003

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(20)
Tagungsberichte
(4)

Sprache

Englisch
(24)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

Treatment with siRNA JNJ-73763989 plus nucleos (t)ide analogue (NA) decreases HBsAg and HDV RNA levels in patients with chronic hepatitis D (CHD): part 1 of the REEF-D study

A longitudinal analysis of hepatitis C virus replication following liver transplantation

Combination Low-Dose Hepatitis B Immune Globulin and Lamivudine Therapy Provides Effective Prophylaxis Against Posttransplantation Hepatitis B

Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy

Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery

Efficacy and safety of Sofosbuvir/Velpatasvir for the treatment of treatment-naive, non-cirrhotic patients with chronic hepatitis C genotype 3 infection: integrated analysis of three phase 3 clinical trials

Liver transplantation for HCV-associated liver cirrhosis: Predictors of outcomes in a population with significant genotype 3 and 4 distribution

Efficacy and Safety of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Treatment-Naive Patients with Chronic HCV Genotype 3: An Integrated Phase 2/3 Analysis

Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From Phase 2 and Phase 3 Trials

Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods

Ribavirin therapy for hepatitis C infection following liver transplantation

Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation

Colonoscopy in unexplained lower gastrointestinal bleeding

Low-cost, simultaneous, single-sequence genotyping of the HLA-A, HLA-B and HLA-C loci

Upper gastrointestinal endoscopy in patients with human immunodeficiency virus infection: is it worthwhile?

Neurological disease in patients with human immunodeficiency virus infection

Fulminant hepatic failure in a young mother

The Impact of Musculoskeletal Injuries Sustained in Road Traffic Crashes on Work-Related Outcomes: A Systematic Review

Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47

Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C

Suchergebnisse filtern